Robust Optimization accounting for Uncertainties

Similar documents
Specifics of treatment planning for active scanning and IMPT

Margins in SBRT. Mischa Hoogeman

Overview. Proton Therapy in lung cancer 8/3/2016 IMPLEMENTATION OF PBS PROTON THERAPY TREATMENT FOR FREE BREATHING LUNG CANCER PATIENTS

IMPT with Carbon Ions

Specification of Tumor Dose. Prescription dose. Purpose

Martin Stuschke 1,2*, Andreas Kaiser 1,2, Jehad Abu Jawad 1, Christoph Pöttgen 1, Sabine Levegrün 1 and Jonathan Farr 2,3

State-of-the-art proton therapy: The physicist s perspective

IGRT Protocol Design and Informed Margins. Conflict of Interest. Outline 7/7/2017. DJ Vile, PhD. I have no conflict of interest to disclose

IMRT FOR CRANIOSPINAL IRRADIATION: CHALLENGES AND RESULTS. A. Miller, L. Kasulaitytė Institute of Oncolygy, Vilnius University

Future upcoming technologies and what audit needs to address

REVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria

Report of ICRU Committee on Volume and Dose Specification for Prescribing, Reporting and Recording in Conformal and IMRT A Progress Report

Range Uncertainties in Proton Therapy

IGRT Solution for the Living Patient and the Dynamic Treatment Problem

Treatment Planning (Protons vs. Photons)

Defining Target Volumes and Organs at Risk: a common language

The objective of this lecture is to integrate our knowledge of the differences between 2D and 3D planning and apply the same to various clinical

A guide to using multi-criteria optimization (MCO) for IMRT planning in RayStation

Clinical considerations of RBE in proton therapy

Advances in external beam radiotherapy

8/3/2016. Clinical Significance of RBE Variations in Proton Therapy. Why RBE (relative biological effectiveness)?

Physics Treatment Margins. Laurence Court University of Texas MD Anderson Cancer Center

Radiation therapy treatment plan optimization accounting for random and systematic patient setup uncertainties

Biological Optimization of Hadrontherapy. Uwe Oelfke

IMRT - the physician s eye-view. Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia

Predicting the risk of developing a radiationinduced second cancer when treating a primary cancer with radiation

7/16/2009. Cost-benefit, QALYs and the Value of a Statistical Life

Role of radiotherapy in the treatment of lymphoma in Lena Specht MD DMSc Professor of Oncology Rigshospitalet, University of Copenhagen Denmark

Accuracy Requirements and Uncertainty Considerations in Radiation Therapy

Evaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer

Treatment Planning Evaluation of Volumetric Modulated Arc Therapy (VMAT) for Craniospinal Irradiation (CSI)

8/3/2016. Implementation of Pencil Beam Scanning (PBS) Proton Therapy Treatment for Liver Patients. Acknowledgement. Overview

IN VIVO IMAGING Proton Beam Range Verification With PET/CT

IMAT: intensity-modulated arc therapy

biij Initial experience in treating lung cancer with helical tomotherapy

1 : : Medical Physics, Città della Salute e della Scienza, Torino, Italy

Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer

Considerations when treating lung cancer with passive scatter or active scanning proton therapy

Radiation treatment planning in lung cancer

The Physics of Oesophageal Cancer Radiotherapy

Lung Spine Phantom. Guidelines for Planning and Irradiating the IROC Spine Phantom. MARCH 2014

Dose prescription, reporting and recording in intensity-modulated radiation therapy: a digest of the ICRU Report 83

Treatment Planning for Skull Base Tumors PTCOG 52, June 2013

8/1/2016. Motion Management for Proton Lung SBRT. Outline. Protons and motion. Protons and Motion. Proton lung SBRT Future directions

Protocol of Radiotherapy for Small Cell Lung Cancer

Optimising Radiotherapy Using NTCP Models: 17 Years in Ann Arbor

Zhengfei Zhu 1,3, Wei Liu 2, Michael Gillin 2, Daniel R Gomez 1, Ritsuko Komaki 1, James D Cox 1, Radhe Mohan 2 and Joe Y Chang 1*

8/2/2012. Transitioning from 3D IMRT to 4D IMRT and the Role of Image Guidance. Part II: Thoracic. Peter Balter, Ph.D.

Efficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO

Dose prescription with spatial uncertainty for peripheral lung SBRT

Discuss the general planning concepts used in proton planning. Review the unique handling of CTV / ITV / PTV when treating with protons

Evaluation of Monaco treatment planning system for hypofractionated stereotactic volumetric arc radiotherapy of multiple brain metastases

SBRT fundamentals. Outline 8/2/2012. Stereotactic Body Radiation Therapy Quality Assurance Educational Session

Non-Hodgkin s Lymphomas Version

Treatment Planning & IGRT Credentialing for NRG SBRT Trials

Accounting for center-of-mass target motion using convolution methods in Monte Carlo-based dose calculations of the lung

Quality assurance and credentialing requirements for sites using inverse planned IMRT Techniques

Pitfalls in SBRT Treatment Planning for a Moving Target

Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk

Application of Implanted Markers in Proton Therapy. Course Outline. McLaren Proton Therapy Center Karmanos Cancer Institute McLaren - Flint

RESEARCH ARTICLE. Abstract. Introduction

Independent Dose Verification for IMRT Using Monte Carlo. C-M M Charlie Ma, Ph.D. Department of Radiation Oncology FCCC, Philadelphia, PA 19111, USA

Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana

Chapter 2. Level II lymph nodes and radiation-induced xerostomia

Chapter 7 General conclusions and suggestions for future work

It s All About Margins. Maaike Milder, Ph.D. Accuray Symposium April 21 st 2018

Protocol of Radiotherapy for Breast Cancer

Proton Therapy for Prostate Cancer. Andrew K. Lee, MD, MPH Director Proton Therapy Center

Epworth Radiation Oncology

8/2/2017. Improving Dose Prescriptions for Safety, Reporting, and Clinical Guideline Consistency. Part III

NSABP PROTOCOL B-39B RTOG PROTOCOL 0413

From position verification and correction to adaptive RT Adaptive RT and dose accumulation

Feasibility of 4D IMRT Delivery for Hypofractionated High Dose Partial Prostate Treatments

The dependence of optimal fractionation schemes on the spatial dose distribution

Radiotherapy Planning (Contouring Lung Cancer for Radiotherapy dose prescription) Dr Raj K Shrimali

Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy

R. Harding, P. Trnková, S. J. Weston, J. Lilley, C. M. Thompson, S. C. Short, C. Loughrey, V. P. Cosgrove, A. J. Lomax, and D. I.

Leila E. A. Nichol Royal Surrey County Hospital

Measure the Errors of Treatment Set-Ups of Prostate Cancer Patient Using Electronic Portal Imaging Device (EPID)

Partial Breast Irradiation using adaptive MRgRT

NDT PERFORMANCE DEMONSTRATION USING SIMULATION

Image Fusion, Contouring, and Margins in SRS

THE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS

CALCULATION OF OPTIMAL MARGINS BETWEEN CLINICAL TARGET VOLUME (CTV) AND PLANNING TARGET VOLUME (PTV)

Estimated risk of radiation-induced lung cancer in paediatric patients following electron, photon and proton therapy

Automated Plan Quality Check with Scripting. Rajesh Gutti, Ph.D. Clinical Medical Physicist

RPC Liver Phantom Highly Conformal Stereotactic Body Radiation Therapy

RTTs role in lung SABR

Changing Paradigms in Radiotherapy

IMRT Planning Basics AAMD Student Webinar

Trajectory Modulated Arc Therapy: Application to Partial Breast Irradiation. Research and development to advance radiotherapy

Stereotactic MR-guided adaptive radiation therapy (SMART) for locally advanced pancreatic tumors

A comprehensive dosimetric study of Monte Carlo and pencil beam algorithms on intensity modulated proton therapy for breast cancer

ICRU Report 91 Was ist neu, was ändert sich?

Larynx-sparing techniques using intensitymodulated radiation therapy for oropharyngeal cancer.

Stereotactic Body Radiotherapy for Lung Lesions using the CyberKnife of-the-art and New Innovations

Review of Workflow NRG (RTOG) 1308: Phase III Randomized Trial Comparing Overall Survival after Photon versus Proton Chemoradiation Therapy for

Assessment of the Margin Simulations of Random and Systematic Errors in Radiotherapy

A VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM *

Evaluation of Three-dimensional Conformal Radiotherapy and Intensity Modulated Radiotherapy Techniques in High-Grade Gliomas

Transcription:

Robust Optimization accounting for Uncertainties Thomas Bortfeld Massachusetts General Hospital, Boston tbortfeld@mgh.harvard.edu Supported by: RaySearch Philips Medical Systems Outline 1. Optimality and uncertainty 2. Robust optimization: better than margins 3. What does all that mean in practice? 1. Optimality and Uncertainty The dilemma: We want the optimal treatment plan for our patients! But, how can we design the optimal plan when the underlying parameters are uncertain? 1

Factors involved in volumetric uncertainty in target volume delineation Decision making by ROs These involve physics Hamilton & Ebert, Clin. Oncol 17: 456-464; 2005 4 The normal way to deal with this: Use margins Pretend that we don t actually want to treat the tumor but the PTV, as uniformly and conformal as possible ICRU 62 Margins to counteract uncertainties Large volumes of normal tissue irradiated Based on assumption that patient moves in a static dose cloud not always justified Issues with overlap of margins (PTV-PRV) 2

Robust optimization = a better way to deal with optimality under uncertainty We want to make a treatment plan as good as possible and at the same time protect it against uncertainties Robustness = immunity to uncertainty Robust optimization: bringing robustness and optimality together How can we do that? Robust optimization, the approach: Consider different scenarios of treatment delivery (instances of geometry of patient positions, organ motion, range over- or undershoot for protons,..) Photon Treatment Planning Collaborative Working Group. IJROBP 21:91-107; 1991 Para-aortic nodes junction Nominal Upper bound Misregistered by 1 cm Lower bound Misregistered by 1 cm 3

Max. Brainstem dose (Gy) Max. Brainstem dose (Gy) IMPT example: chordoma 29 different scenarios: Nominal scenario (1) 3 mm setup error ±x, ±y, ±z (6) 3 mm setup error (diagonal) (20) 5% range error, over- and undershoot (2) Planning tradeoff, nominal case P1 Plans of OPT (K=1) CTV underdose (Gy) Plan degradation P1 Plans of OPT (K=1) evaluated at K=29 P1 Plans of OPT (K=1) CTV underdose (Gy) 4

Max. Brainstem dose (Gy) Robust optimization, the approach: Consider different scenarios of treatment delivery (instances of geometry of patient positions, organ motion, range over- or undershoot for protons,..) 1. The worst case approach: make sure that constraints are fulfilled in all scenarios, and that we obtain the best plan in the worst case ( minimax ). Robust solution (worst case, minimax) P1 Plans of OPT (K=1) evaluated at K=29 P2 Plans of OPT (K=29) P1 Plans of OPT (K=29) evaluated at K=1 Plans of OPT (K=1) CTV underdose (Gy) Robust optimization, the approach: Consider different scenarios of treatment delivery (instances of geometry of patient positions, organ motion, range over- or undershoot for protons,..) 1. The worst case approach: make sure that constraints are fulfilled in all scenarios, and that we obtain the best plan in the worst case ( minimax ). 2. Stochastic programming : describe uncertainties with random variables, assume probability density functions (pdf), and optimize expected value of the objective function. 5

The price of robustness non-robust (Plan A) and robust (Plan B) Price of robustness! Outline 1. Optimality and uncertainty 2. Robust optimization: better than margins 3. What does all that mean in practice? Example: setup error (1D) Error scenarios defined by shifting to the left or right in steps of 1mm. Random error: 32 random shifts (for 32 fractions) sampled from a Gaussian with a mean of zero and a set standard deviation σ Rand Systematic error: single shift with standard deviation σ Sys added to the random shift above 6

Example: setup error (1D) (10 mm) 2 Observations random/systematic errors: Random errors require smaller margins than systematic errors -> van Herk margin recipes. Robust optimization leads to beam horns instead of margins. IMPT plan, 3 fields target spinal cord 7

Sensitivity analysis Stochastic programming Target dose deviation Spinal cord dose 3 scenarios: Scenario 1: Nominal scenario, p 1 = 0.5 Scenario 2: 5 mm range overshoot, p 2 = 0.25 Scenario 3: 5 mm range undershoot, p 3 = 0.25 healthy tissue dose Robust IMPT plan 8

Sensitivity analysis II (robust plan) Observations protons: Proton range errors in IMPT cannot effectively be dealt with through margins. Here we absolutely need robust optimization. More on robust optimization for protons: IMPT session, talk by Jan Unkelbach et al. Thursday, 7:30-9:30AM, Ballroom E Vision for the future No (PTV) margins in treatment planning Instead, quantify motion and uncertainties, and let the planning system find a robust solution. This may be a margin-like solution but could also be an advanced intensitymodulated solution (e.g., horns ). 9

Outline 1. Optimality and uncertainty 2. Robust optimization: better than margins 3. What does all that mean in practice? Implementation in RayStation 4.5 User interface Setup uncertainty Range uncertainty Implementation in RayStation 4.5 10

Robust optimization Take-home-messages: Uncertainty -> Different scenarios Robust optimization done in two ways: 1. optimize worst scenario (minimax) 2. stochastic programming (optimization of expected outcome) There is always a price of robustness. Robust optimization can lead to new types of fault-tolerant dose distributions, e.g. beam horns for motion, and robust proton dose distributions. Robust optimization is coming to you (i.e., to your planning system). Uncertainty analysis and robustness 30 year old dreams come true Med Phys 12(5):608-612, 1985 11

Planning objectives and constraints Learning objective To highlight the basic ideas and clinical potential of robust optimization procedures to generate optimal treatment plans that are not severely affected by uncertainties. Uncertainty and Motion Motion does not necessarily imply uncertainty If motion is perfectly known, then there is no uncertainty. This case is easy to deal with. But, when there is motion (e.g., breathing), there are typically more potential sources of uncertainty: Uncertainties in the motion characteristics such as frequency, amplitude, shape of trajectory, irregularity of the motion. 12

Uncertainty model for de-blurring method PDF for regular breathing Uncertain motion may lead to many PDFs Motion p PDF Displacement or phase Displacement or phase Uncertainty set PDF and error bars realized pdf p(x) ~ p(x) nominal PDF p(x) p(x) position (phase) (x) Tim Chan et al: Phys Med Biol 51:2567 (2006) 13

Observations re. breathing motion: If we know nothing about the motion but the rough amplitude, adding margins is the best we can do. If we know more, such as the breathing PDF, we can do much better with robust optimization. 14